BMS Texas investment advances pharma’s modular manufacturing agenda
The company’s flexible production, aided by its multi-modal capabilities, adds to pioneering work by Sanofi, Bayer and Pfizer.
Drug Manufacturers
Industry partnership will determine the success of the transition to low-GWP pMDIs
Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing
Turning AI skeptics into AI advocates through high-integrity data
Altaris to acquire Simulations Plus in $375m all-cash deal
University of Edinburgh develops cell therapy for liver disease
Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities
GSK and SBP Group team up to advance bepirovirsen launch in China
